These findings strongly suggest that cytotoxic CD8+ T cells promote inflammatory responses and disease progression in a variety of autoimmune and neurological diseases by secreting GzmB, making GzmB a potential therapeutic target for these diseases and NMOSD. This evidence concerns the gene CD8A and nervous system disorder.